Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data - PubMed (original) (raw)
Comparative Study
Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data
Danielle A Southern et al. Med Care. 2004 Apr.
Abstract
Background: Comorbidity risk adjustment methods have been used widely with administrative data, and the Charlson/Deyo method is perhaps the most commonly used in the literature. However, a new method defined by Elixhauser et al. has been introduced recently and could be superior, although it has not been validated widely.
Objectives: We compared the Charlson/Deyo and Elixhauser methods using Canadian administrative data on patients with myocardial infarction (MI).
Research design: We conducted a historical cohort study.
Subjects: We used administrative hospital discharge data from a large Canadian city for all cases with acute MI coded as most responsible diagnosis between January 1, 1995, and March 31, 2001.
Measures: We used each of the 2 methods to define comorbidity variables based on the International Classification of Diseases, 9th Revision, Clinical Modification codes present in each case record. We then compared 2 models predicting in-hospital mortality based on presence or absence of the variables defined by each of the methods. Frequency tables were produced and c-statistics and changes in -2 log likelihood (-2LogL) were calculated. We also visually assessed model performance by plotting observed and expected percentages of death for increasing risk categories defined by the 2 models.
Results: The Elixhauser model outperformed the Charlson/Deyo model in predicting mortality, with higher c-statistic values (0.793 vs. 0.704). Superior performance of the Elixhauser method is confirmed when plotting the expected and observed risks of death across groupings of increasing risk, in which the Elixhauser method yields a wider range of predicted and observed probabilities of death across groupings (2.5%-33%) than does the Charlson/Deyo method (5%-25%).
Conclusions: The Elixhauser comorbidity measurement method performs better than the widely used Charlson/Deyo method in the Canadian acute MI cases studied.
Similar articles
- Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality.
Chu YT, Ng YY, Wu SC. Chu YT, et al. BMC Health Serv Res. 2010 May 27;10:140. doi: 10.1186/1472-6963-10-140. BMC Health Serv Res. 2010. PMID: 20507593 Free PMC article. - Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions.
Gutacker N, Bloor K, Cookson R. Gutacker N, et al. Eur J Public Health. 2015 Feb;25 Suppl 1:15-20. doi: 10.1093/eurpub/cku221. Eur J Public Health. 2015. PMID: 25690125 - Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.
Li B, Evans D, Faris P, Dean S, Quan H. Li B, et al. BMC Health Serv Res. 2008 Jan 14;8:12. doi: 10.1186/1472-6963-8-12. BMC Health Serv Res. 2008. PMID: 18194561 Free PMC article. - Risk Adjustment Instruments in Administrative Data Studies: A Primer for Neurosurgeons.
Kim LH, Chen YR. Kim LH, et al. World Neurosurg. 2019 Aug;128:477-500. doi: 10.1016/j.wneu.2019.04.179. Epub 2019 Apr 30. World Neurosurg. 2019. PMID: 31048059 Review. - Effect of comorbidity on injury outcomes: a review of existing indices.
Fernando DT, Berecki-Gisolf J, Newstead S, Ansari Z. Fernando DT, et al. Ann Epidemiol. 2019 Aug;36:5-14. doi: 10.1016/j.annepidem.2019.06.004. Epub 2019 Jun 21. Ann Epidemiol. 2019. PMID: 31327673 Review.
Cited by
- Graves disease is associated with increased risk of clinical Alzheimer's disease: evidence from the Medicare system.
Yashkin AP, Kolpakov S, Ukraintseva S, Yashin A, Akushevich I. Yashkin AP, et al. Clin Diabetes Endocrinol. 2024 Feb 5;10(1):11. doi: 10.1186/s40842-024-00170-z. Clin Diabetes Endocrinol. 2024. PMID: 38317215 Free PMC article. - Association of hospital participation in a quality reporting program with surgical outcomes and expenditures for Medicare beneficiaries.
Osborne NH, Nicholas LH, Ryan AM, Thumma JR, Dimick JB. Osborne NH, et al. JAMA. 2015 Feb 3;313(5):496-504. doi: 10.1001/jama.2015.25. JAMA. 2015. PMID: 25647205 Free PMC article. - Primary Care Prognostic (PCP) Index of 11-Year Mortality Risk: Development and Validation of a Brief Prognostic Tool.
Chiang GSH, Nyunt MSZ, Gao Q, Wee SL, Yap KB, Tan BY, Ng TP. Chiang GSH, et al. J Gen Intern Med. 2021 Jan;36(1):62-68. doi: 10.1007/s11606-020-06132-2. Epub 2020 Aug 20. J Gen Intern Med. 2021. PMID: 32820420 Free PMC article. - Is thirty-day hospital mortality really lower for black veterans compared with white veterans?
Volpp KG, Stone R, Lave JR, Jha AK, Pauly M, Klusaritz H, Chen H, Cen L, Brucker N, Polsky D. Volpp KG, et al. Health Serv Res. 2007 Aug;42(4):1613-31. doi: 10.1111/j.1475-6773.2006.00688.x. Health Serv Res. 2007. PMID: 17610440 Free PMC article. - Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.
Zullo AR, Sharmin S, Lee Y, Daiello LA, Shah NR, John Boscardin W, Dore DD, Lee SJ, Steinman MA. Zullo AR, et al. J Am Geriatr Soc. 2017 Nov;65(11):2397-2404. doi: 10.1111/jgs.15144. Epub 2017 Oct 17. J Am Geriatr Soc. 2017. PMID: 29044457 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical